These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9519015)

  • 21. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
    Kozek-Langenecker SA; Spiss CK; Gamsjäger T; Domenig C; Zimpfer M
    Wien Klin Wochenschr; 2002 Feb; 114(3):96-101. PubMed ID: 12060975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin dosing: a comparison of weight-based dosing vs standard dosing.
    White CM
    Conn Med; 1997 Feb; 61(2):103-4. PubMed ID: 9066199
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence of in vivo platelet activation during heparin anticoagulation in pregnancy for prophlaxis or treatment of thromboembolism.
    Ajayi AA; Horn EH; Rubin PC
    Afr J Med Med Sci; 1999; 28(1-2):113-5. PubMed ID: 12953999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of major bleeding in unselected patients with venous thromboembolism.
    Bigaroni A; Perrier A; de Moerloose P; Perneger T; Bounameaux H
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):199-202. PubMed ID: 10759014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cephalin-heparin test. Proposed new test for control of anticoagulant therapy].
    Triginer J; Gomez-Granda LG; Fernandez Cavada JP; Quesada R
    Sangre (Barc); 1965; 10(3):245-54. PubMed ID: 5864587
    [No Abstract]   [Full Text] [Related]  

  • 26. Different effects of heparin in males and females.
    Campbell NR; Hull RD; Brant R; Hogan DB; Pineo GF; Raskob GE
    Clin Invest Med; 1998 Apr; 21(2):71-8. PubMed ID: 9562927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
    Bergqvist D
    Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
    [No Abstract]   [Full Text] [Related]  

  • 28. [Protocol for ambulant treatment of deep venous thrombosis in a leg: efficacious and safe in general practice].
    van Hulsteijn LH; Brenninkmeijer BJ; Trügg RA; Litjens-van de Ven AJ; Huisman MV
    Ned Tijdschr Geneeskd; 2000 Mar; 144(12):557-60. PubMed ID: 10746047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina.
    Klootwijk P; Lenderink T; Meij S; Boersma H; Melkert R; Umans VA; Stibbe J; Müller EJ; Poortermans KJ; Deckers JW; Simoons ML
    Eur Heart J; 1999 Aug; 20(15):1101-11. PubMed ID: 10413640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Compression therapy in deep venous thrombosis].
    Manganaro A; Buda D; Ando G; Consolo F
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):57-60. PubMed ID: 11253342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical inquiries. What is the best therapy for superficial thrombophlebitis?
    Neher JO; Safranek S; Greenwald JL
    J Fam Pract; 2004 Jul; 53(7):583-5. PubMed ID: 15251103
    [No Abstract]   [Full Text] [Related]  

  • 32. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 33. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
    Delis KT; Hunt N; Strachan RK; Nicolaides AN
    Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current considerations in the use of the APTT in monitoring unfractionated heparin.
    Nelson DE
    Clin Lab Sci; 1999; 12(6):359-64. PubMed ID: 10724634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF; Matheny SC
    Am Fam Physician; 1999 Feb; 59(4):945-52. PubMed ID: 10068716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy and deep vein thrombosis.
    Bates SM; Ginsberg JS
    Semin Vasc Med; 2001; 1(1):97-104. PubMed ID: 15199519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 40. [Infusion thrombophlebitis and local anticoagulation therapy with heparin].
    Thayssen P
    Ugeskr Laeger; 1974 Jul; 136(30):1679-82. PubMed ID: 4610936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.